NovaQuant Quantitative Think Tank Center|Honda recalls nearly 1.2 million cars over faulty backup camera

2025-05-07 19:21:27source:FinLogic Quantitative Think Tank Centercategory:Scams

Honda recalls 1.2 million minivans, SUVs
Honda recalls 1.2 million minivans, SUVs00:31

Honda is recalling nearly 1.2 million cars because the rearview camera images may not appear on the dashboard screen. 

The recall includes Passport SUVs from 2019 to 2023, in addition to Pilot SUVs from 2019 to 2022, the National Highway Traffic Safety Administration (NHTSA) said on June 15. It also covers some Odyssey minivans from 2018 to 2023.

An "improperly manufactured" coaxial cable connector was the cause of the connectivity issues between the rearview camera images and the vehicles' dashboard displays, Honda said in a Friday recall notice. 

"If the [Media Oriented Systems Transport] communication is lost for more than 20 seconds, the rearview camera function will fail when the vehicle is in the reverse gear, increasing the risk of a crash or injury," Honda said in the recall notice. 

Dealers will replace the cable harness and install a straightening cover over the vehicle cable connector free of charge, the carmaker said. Car owners who have already paid to repair their vehicles at their own expense are eligible for reimbursement.

Honda expects to mail notification letters to affected car owners on July 24. Until then, customers can contact Honda's customer service line at 1-888-234-2138. The NHTSA said Honda's numbers for the recall are EEL and ZEM. 

    In:
  • Product Recall
  • Honda

More:Scams

Recommend

Angie Murimirwa: From hiding in the bathroom to Time's most influential people list

I don't mean to humble brag, but I am on a first name basis with one of the most influential people

Inside Clean Energy: This Virtual Power Plant Is Trying to Tackle a Housing Crisis and an Energy Crisis All at Once

Vicken Kasarjian is giddy as he describes a project that aims to address two of Richmond, California

Drugmaker Mallinckrodt may renege on $1.7 billion opioid settlement

The generic drugmaker Mallinckrodt says the company's board might not make a $200 million opioid set